FDAAA Title IX: Enhanced Authorities Regarding Postmarket Safety of Drugs
- Risk Evaluation and Mitigation Strategies (REMS) (Section 505)
- Federal Register Notice [HTML] [PDF]
- Questions and Answers on the Federal Register Notice
Date created: May 7, 2008